Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | proteasome PrcB | 0.0423 | 1 | 1 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0158 | 0.2153 | 0.1669 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0423 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0176 | 0.2692 | 0.2241 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0423 | 1 | 1 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0423 | 1 | 1 |
Trypanosoma brucei | proteasome beta 6 subunit | 0.0158 | 0.2153 | 0.1669 |
Loa Loa (eye worm) | nucleolar RNA-associated protein alpha | 0.032 | 0.695 | 0.6762 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0423 | 1 | 1 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0158 | 0.2153 | 0.1669 |
Brugia malayi | hypothetical protein | 0.0157 | 0.2127 | 0.2127 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0423 | 1 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0423 | 1 | 1 |
Echinococcus granulosus | proteasome prosome macropain | 0.0423 | 1 | 1 |
Echinococcus granulosus | snurportin 1 | 0.032 | 0.695 | 0.6762 |
Echinococcus granulosus | geminin | 0.0176 | 0.2692 | 0.2241 |
Plasmodium vivax | proteasome subunit beta type-1, putative | 0.0158 | 0.2153 | 0.1669 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0158 | 0.2153 | 0.1669 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0158 | 0.2153 | 0.1669 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0423 | 1 | 1 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0423 | 1 | 1 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0423 | 1 | 1 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0423 | 1 | 1 |
Schistosoma mansoni | proteasome subunit beta 1 (T01 family) | 0.0158 | 0.2153 | 0.1669 |
Schistosoma mansoni | hypothetical protein | 0.0176 | 0.2692 | 0.2241 |
Leishmania major | proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, putative | 0.0158 | 0.2153 | 0.1669 |
Mycobacterium tuberculosis | Proteasome beta subunit PrcB; assembles with alpha subunit PrcA. | 0.0423 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0176 | 0.2692 | 0.2241 |
Loa Loa (eye worm) | proteasome subunit beta type 1 | 0.0158 | 0.2153 | 0.1669 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0423 | 1 | 1 |
Giardia lamblia | Proteasome subunit beta type 1 | 0.0158 | 0.2153 | 0.1669 |
Schistosoma mansoni | hypothetical protein | 0.032 | 0.695 | 0.6762 |
Trypanosoma cruzi | proteasome beta 6 subunit, putative | 0.0158 | 0.2153 | 0.1669 |
Plasmodium falciparum | proteasome subunit beta type-1, putative | 0.0158 | 0.2153 | 0.1669 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0423 | 1 | 1 |
Echinococcus multilocularis | snurportin 1 | 0.032 | 0.695 | 0.6762 |
Loa Loa (eye worm) | hypothetical protein | 0.0157 | 0.2127 | 0.1642 |
Toxoplasma gondii | proteasome subunit beta type 1, putative | 0.0158 | 0.2153 | 0.1669 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0423 | 1 | 0.5 |
Entamoeba histolytica | proteasome subunit beta type 1, putative | 0.0158 | 0.2153 | 0.1669 |
Brugia malayi | proteasome subunit beta type 1 | 0.0158 | 0.2153 | 0.2153 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0423 | 1 | 1 |
Onchocerca volvulus | 0.0157 | 0.2127 | 0.5 | |
Brugia malayi | proteasome subunit beta type 2 | 0.0105 | 0.0581 | 0.0581 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 220 nM | Compound was evaluated for inhibition of ex vivo ADP mediated platelet aggregation of human gel filtered platelets | ChEMBL. | No reference |
IC50 (functional) | = 220 nM | Compound was evaluated for inhibition of ex vivo ADP mediated platelet aggregation of human gel filtered platelets | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.